Preclinical research in Rett syndrome: setting the foundation for translational success

Interesting article by Dr. Katz and colleagues

Click here to read the full article.

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3484856/?report=reader

New Hope: A Safety Study of NNZ-2566 in Patients With Rett Syndrome

This study is not yet open for participant recruitment.

Sponsor:

Neuren Pharmaceuticals Limited

Collaborators:

Baylor College of Medicine

Texas Children's Hospital

International Rett Syndrome Foundation

More information regarding this can be found on the links below. Kindly click on the links to read further.

http://clinicaltrials.gov/ct2/show/NCT01703533?term=Rett+Syndrome&rank=4

http://newsstore.fairfax.com.au/apps/previewDocument.ac?sy=age&ss=AGE&docID=GCA01358630NEU&backTo%3Dhttp%3A%2F%2Fmarkets.theage.com.au%2Fapps%2Fqt%2Fquote.ac%3Fcode%3Dneu%26submit%3DSearch%26securityType%3D0%26section%3Dsummary%26sortBy%3D0%26descContains%3D0&f=pdf

Source: ClinicalTrials.gov